|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 215/22 | |
| A61K 31/47 | |||
| A61P 35/00 |
| (11) | Number of the document | 3274333 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16711818.1 |
| Date of filing the European patent application | 2016-03-22 | |
| (97) | Date of publication of the European application | 2018-01-31 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/056262 |
| Date | 2016-03-22 |
| (87) | Number | WO 2016/150963 |
| Date | 2016-09-29 |
| (30) | Number | Date | Country code |
| 15160877 | 2015-03-25 | EP |
| (72) |
STEFINOVIC, Marijan, AT
SCHREINER, Erwin, Paul, AT
|
| (73) |
Sandoz AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | CABOZANTINIB SALTS AND THEIR USE AS ANTI-CANCER AGENTS |
| CABOZANTINIB SALTS AND THEIR USE AS ANTI-CANCER AGENTS |